Multipotent neural stem cells
An isolated multipotent neural stem cells has a phenotype identified by expression of the protein β-tubulin IV and Olig2 and the absence of the proteins NG2, PLP, and GFAP.
1. An isolated and enriched population of human multipotent neural stem cells, the cells expressing the protein β-tubulin IV (βT4) and oligodendrocyte 2 (Olig2) and not expressing the proteins neural/glial cell 2 (NG2), proteolipid protein (PLP), and glial fibrillary acidic protein (GFAP), the cells being capable of differentiating into cells of more than one neural lineage.
2. The isolated and enriched population of human multipotent neural stem cells of claim 1 , the cells being resistant to the antimetabolic effects of cytosine-β-D-arabinofuranoside (Ara-C).
3. The isolated and enriched population of human multipotent neural stem cells of claim 1 , being isolated from neural tissue.
4. The isolated and enriched population of human multipotent neural stem cell cells of claim 1 , being isolated from a subventricular zone of a mammal brain.
5. The isolated and enriched population of human multipotent neural stem cells of claim 1 , being genetically modified to express at least one protein or peptide.
6. The isolated and enriched population of human multipotent neural stem cells of claim 1 , being genetically modified to express at least one growth factor or protein that can be used in the treatment of a central nervous system disorder.
7. The isolated and enriched population of human multipotent neural stem cells of claim 6 , the growth factor or protein being selected from the group consisting of Shh, BMP, NGF, BDNF, neurotrophins, CNTF, amphiregulin, FGF-1, FGF-2, EGF, TGFα, TGFβ, PDGF, IGF, and interleukin.
8. The isolated and enriched population of human multipotent neural stem cells of claim 1 , wherein greater than 83% of the cells are BT4 positive.